ArticleCureus2024
Severe Transverse Myelitis Following Ankle Surgery Potentially Unmasking Late-Onset Systemic Lupus Erythematosus.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A 70-year-old female underwent open reduction and internal fixation (ORIF) of her right ankle following a mechanical trip and fell two weeks before hospital admission. Two weeks following surgery, the patient experienced sudden-onset bilateral anterior thigh paresthesias and burning mid-back pain. Over the ensuing two days, the patient developed bilateral lower extremity weakness, bilateral lower extremity numbness, and urinary retention with constipation, which led to hospital presentation. A non-contrast cervical/thoracic/lumbar spine MRI on the day of admission revealed a possible syrinx from T3-T12. A repeat thoracic spine MRI revealed enhancement of the spinal cord at T9-T10 and T11-T12, suggestive of transverse myelitis or spinal cord infarction. Initiation of IV methylprednisolone sodium succinate improved strength and sensation, and IVIG (intravenous immunoglobulin) therapy was initiated. Transverse myelitis is typically idiopathic or attributed to infectious causes or systemic autoimmune conditions. Spinal cord injury remained high on the differential diagnosis, considering transverse myelitis rarely presents in the postoperative period. While methylprednisolone sodium succinate is the first-line treatment for transverse myelitis, its role remains unclear in treating spinal cord injury. Given the patient's positive response to methylprednisolone sodium succinate, an autoimmune panel was sent to determine the underlying etiology, resulting in a positive ANA (antinuclear antibody) and anti-dsDNA. Thus, transverse myelitis may be an initial presentation of systemic lupus erythematosus (SLE). In rare cases of spinal cord injury versus immune-mediated disorders affecting the spinal cord, corticosteroid treatment should be considered pending diagnosis confirmation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.